Opendata, web and dolomites

Bio-AX

A new wearable, cost effective and non-invasive biometric solution for accurate and high throughput screening of people, bags and vehicles

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Bio-AX" data sheet

The following table provides information about the project.

Coordinator
AUDAX GLOBAL SOLUTIONS LIMITED 

Organization address
address: UNIT 16 MARY SEACOLE ROAD, THE MILLFIELDS
city: PLYMOUTH
postcode: PL1 3JY
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.audaxuk.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.7. (Secure societies - Protecting freedom and security of Europe and its citizens)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-06-01   to  2015-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AUDAX GLOBAL SOLUTIONS LIMITED UK (PLYMOUTH) coordinator 50˙000.00

Map

 Project objective

AUDAX Global Solutions Ltd. is an SME founded in Plymouth UK in 2005. Since then it has become a pioneer in the delivery and development of mobile digital evidence gathering products and services. The AUDAX team consists of the most knowledgeable experts in the industry who are committed to offer ground breaking innovative solutions. AUDAX owns a new technology Bio-AX™, a new wearable, cost-effective and non-invasive biometric solution for accurate and high throughput screening of people, bags and vehicles. This technology will bring many benefits to the stakeholders and increase security in our communities. AUDAX sees a huge business opportunity through sales. The uniqueness of Bio-AX™ will increase the Unique Selling Proposition (USP) of our products and competitive advantage in the market. AUDAX believes that Bio-AX™ will raise the Company’s profitability and grow its workforce. AUDAX has invested in Bio-AX™ and it is now in prototype phase. However, the Company requires further financing through SME Instrument to fund the transition of the prototype into commercialisation. In Phase 1 our specific objective is to prepare a clear Feasibility Study and Business Plan to determine the feasibility, possibility, viability and sustainability of this new project.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIO-AX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIO-AX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.7.;H2020-EU.2.3.1.)

SRAP (2018)

Safe and Readily Authenticated Pharmaceutical dosage forms (tablets)

Read More  

Quakebots (2018)

Artificial Intelligence and IoT for seismic monitoring

Read More  

Probe.ly (2018)

PROBE.LY - Web Application Vulnerability Scanning Suite for Agile Teams

Read More